- Report
- May 2023
- 150 Pages
Global
From €5246EUR$5,950USD£4,607GBP
- Report
- August 2024
- 130 Pages
North America
From €3526EUR$4,000USD£3,097GBP
- Report
- May 2024
- 180 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- May 2024
- 85 Pages
Spain
From €3086EUR$3,500USD£2,710GBP
- Report
- November 2023
- 71 Pages
France
From €3086EUR$3,500USD£2,710GBP
- Report
- October 2022
- 118 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- August 2022
- 242 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- December 2024
- 175 Pages
Global
From €4408EUR$5,000USD£3,872GBP
- Report
- July 2024
- 100 Pages
Global
From €2645EUR$3,000USD£2,323GBP
€3306EUR$3,750USD£2,904GBP
- Report
- May 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,213GBP
- Report
- March 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,213GBP
- Report
- October 2023
- 145 Pages
Global
From €2777EUR$3,150USD£2,439GBP
- Report
- May 2024
- 111 Pages
North America
From €3042EUR$3,450USD£2,671GBP
- Report
- July 2024
- 105 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- February 2024
- 95 Pages
North America
From €4188EUR$4,750USD£3,678GBP
- Report
- February 2024
- 115 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- February 2024
- 119 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- April 2023
- 80 Pages
Asia Pacific
From €4188EUR$4,750USD£3,678GBP
- Report
- May 2024
- 237 Pages
Global
From €3923EUR$4,450USD£3,446GBP
- Report
- March 2024
- 150 Pages
Global
From €3923EUR$4,450USD£3,446GBP

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more